Randall Bateman, M.D.

Charles F. and Joanne Knight Distinguished Professor of Neurology,

Washington University School of Medicine

Dr. Randall Bateman attended Washington University where he received a B.S. degree in Biology and also in Electrical Engineering. He then received a M.D. at Case Western Reserve University School of Medicine.

Dr. Bateman is the Director of the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), which coordinates with pharmaceutical, regulatory, and patient advocacy groups for clinical trials in the DIAN. Dr. Bateman also serves as the Associate Director of the Dominantly Inherited Alzheimer Network (DIAN), the DIAN Clinical Core leader, and the Washington University DIAN Performance Site PI. Dr. Bateman is the recipient of multiple grants and awards from the NIH and outside agencies.

Dr. Bateman’s laboratory investigates the causes and future diagnostic tests and treatments of Alzheimer's disease utilizing a wide variety of assays and techniques from quantitative measurement of stable-isotope labeled proteins to clinical translational studies for Alzheimer's disease. Recent awards include Scientific American 50, top 50 scientific advancements of 2006, Beeson Award (2007), the Glenn Award for Research (2011), the Alzforum Open Innovation Award (2011), the Metlife Promising Investigator Award (2012), and the Chancellor’s Entrepreneurship and Innovation Award (2013).

Funded Research

Project Description Researchers Funding
Orbitrap Fusion Tribid Mass Sprectrometer
The proposed grant will assist in the purchase of an Orbitrap Fusion Tribrid Mass Spectrometer system to
enable the development of a method to assess tau production and clearance rates in humans, animal models,
and in vitro experiments. This cutting edge mass spectrometer system will provide more precise measurements
with the ultra-low abundance of biomolecules of interest than current instruments can quantify. This will allow for
2014
$200,000